The Group VIA Phospholipase A 2 (iPLA 2 ) is the first recognized cytosolic Ca 2؉ -independent PLA 2 and has been proposed to participate in arachidonic acid (20:4) incorporation into glycerophosphocholine lipids, cell proliferation, exocytosis, apoptosis, and other processes. To study iPLA 2  functions, we disrupted its gene by homologous recombination to generate mice that do not express iPLA 2 . Heterozygous iPLA 2  ؉/؊ breeding pairs yield a Mendelian 1:2:1 ratio of iPLA 2  ؉/؉ , iPLA 2  ؉/؊ , and iPLA 2  ؊/؊ pups and a 1:1 male:female gender distribution of iPLA 2  ؊/؊ pups. Several tissues of wild-type mice express iPLA 2  mRNA, immunoreactive protein, and activity, and testes express the highest levels. Testes or other tissues of iPLA 2  ؊/؊ mice express no iPLA 2  mRNA or protein, but iPLA 2  ؊/؊ testes are not deficient in 20:4-containing glycerophosphocholine lipids, indicating that iPLA 2  does not play an obligatory role in formation of such lipids in that tissue. Spermatozoa from iPLA 2  ؊/؊ mice have reduced motility and impaired ability to fertilize mouse oocytes in vitro and in vivo, and inhibiting iPLA 2  with a bromoenol lactone suicide substrate reduces motility of wild-type spermatozoa in a time-and concentration-dependent manner. Mating iPLA 2  ؊/؊ male mice with iPLA 2  ؉/؉ , iPLA 2  ؉/؊ , or iPLA 2  ؊/؊ female mice yields only about 7% of the number of pups produced by mating pairs with an iPLA 2  ؉/؉ or iPLA 2  ؉/؊ male, but iPLA 2  ؊/؊ female mice have nearly normal fertility. These findings indicate that iPLA 2  plays an important functional role in spermatozoa, suggest a target for developing male contraceptive drugs, and complement reports that disruption of the Group IVA PLA 2 (cPLA 2 ␣) gene impairs female reproductive ability.